Patient Note — 171112
progress_notes_171112_1_deid.txt
Demographics & Encounter
Patient ID171112 (PHI redacted)
Age / Gender— / —
Date of Service2026-01-23
Provider[PROVIDER_NAME]
FacilityPOTOMAC UROLOGY CENTER - Manassas
PayerCigna Open Access Plus
Reason1. 3 MONTH F/U
Diagnoses
R97.20
Elevated PSA
N40.0
Benign prostatic hyperplasia without urinary obstruction
R31.0
Gross hematuria
N52.9
Erectile dysfunction, unspecified erectile dysfunction type
Medications
Finasteride
Diclofenac Sodium
Cyclobenzaprine HCl
HYDROcodone-Acetaminophen 7.5-325 MG Tablet Oral
Carvedilol
Valsartan-hydroCHLOROthiazide 320-25 MG Tablet Oral
Atorvastatin Calcium
hydrALAZINE HCl
Tamsulosin HCl 0.4 MG Capsule 1 cap(s) orally once a day
Progress Note: [PROVIDER_NAME], MD 01/23/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/16/2026 03:33 AM EDT
1/4
4/16/26, 12:34 AM Print Preview
[PATIENT_NAME] DOB: [DOB] ([AGE] yo M) Acc No. [ACCOUNT_ID] DOS: 01/23/2026
Tadalafil
Cialis(Tadalafil)
metFORMIN HCl ER
Meloxicam
Medication List reviewed and reconciled with the patient
Past Medical History
- Mixed hyperlipidemia
- Essential (primary) hypertension
- Type 2 diabetes mellitus with unspecified complications
- Elevated prostate specific antigen (PSA)
Vitals
RR
18.0
HR
84.0
BP
130/82
BMI
31.01
WEIGHT
204 lbs
HEIGHT_IN
68.0
Clinical Summary (HPI)
General Urology: [AGE] yM with hx of ED, BPH and elevated PSA presents today for 3-month FU. He reports an episode of hematuira. No dysuria. He does notes his symptoms are slowing worsening. on finasteride and Flomax. ========================= Prior hx: He denies dysuria, No urgency, frequency, or leaking. No GH. He is off finasteride. Is not sexually active. [ADDRESS] Arnold about 8-10 yrs ago. ========================= The patient's past workup includes: Labs (01/2026): HbA1c 6.4, Cr 1.27, CMP wnl PSA: 15.5 (01/2026-On finasteride), 24.6, %F 9 (10/2025, On finasteride) 10.5 (Mar'24); 5.8 (Sep'23); 8.0 (Apr'23); 13.3 (Sep'22); 10.8 (Aug'21); 8.14 (Jul'20); 9.56 (Jan'20); 8.4 (May'19) Labs (10/2025): HbA1c 6.5 MRI Prostate (11/2024): There are no certain or identifiable findings to corrspnd with any focus of clinically significant abnormality. marked BPH with overall gland size measured at 108g US (2022): 111cc prostate volume without suspicous masses. Elevated PSA: Prior biopsy reports were negative.
Raw Note (de-identified preview)
4/16/26, 12:34 AM Print Preview
[PATIENT_NAME] DOB: [DOB] ([AGE] yo M) Acc No. [ACCOUNT_ID] DOS: 01/23/2026
[PATIENT_NAME]
[AGE] Y old Male, DOB: [DOB]
Account: [ACCOUNT_ID]: [PHONE] [ADDRESS]
Home: [PHONE]
Guarantor: [GUARANTOR_NAME] Insurance: Cigna Open Access Plus
PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME]
Appointment Facility: POTOMAC UROLOGY CENTER - Manassas
Structured Data: How did you hear about us? : Other; Patient's temperature : 0
01/23/2026 Progress Notes: [PROVIDER_NAME], MD
Reason for Appointment
1. 3 MONTH F/U
History of Present Illness
General Urology:
[AGE] yM with hx of ED, BPH and elevated PSA presents today for 3-month FU.
He reports an episode of hematuira. No dysuria.
He does notes his symptoms are slowing worsening. on finasteride and Flomax.
=========================
Prior hx:
He denies dysuria, No urgency, frequency, or leaking. No GH. He is off finasteride. Is not sexually active.
[ADDRESS] Arnold about 8-10 yrs ago.
=========================
The patient's past workup includes:
Labs (01/2026): HbA1c 6.4, Cr 1.27, CMP wnl
PSA: 15.5 (01/2026-On finasteride), 24.6, %F 9 (10/2025, On finasteride) 10.5 (Mar'24); 5.8 (Sep'23); 8.0 (Apr'23);
13.3 (Sep'22); 10.8 (Aug'21); 8.14 (Jul'20); 9.56 (Jan'20); 8.4 (May'19)
Labs (10/2025): HbA1c 6.5
MRI Prostate (11/2024): There are no certain or identifiable findings to corrspnd with any focus of clinically significant
abnormality. marked BPH with overall gland size measured at 108g
US (2022): 111cc prostate volume without suspicous masses.
Elevated PSA:
Prior biopsy reports were negative.
Current Medications
Taking
Finasteride 5 MG Tablet 1 tablet Orally Once a day
Diclofenac Sodium 75 MG Tablet Delayed Release Oral
Cyclobenzaprine HCl 10 MG Tablet Oral
HYDROcodone-Acetaminophen 7.5-325 MG Tablet Oral
Carvedilol 25 MG Tablet Oral
Valsartan-hydroCHLOROthiazide 320-25 MG Tablet Oral
Atorvastatin Calcium 80 MG Tablet Oral
hydrALAZINE HCl 50 MG Tablet Oral
Finasteride 5 MG Tablet 1 tab(s) orally once a day
Tamsulosin HCl 0.4 MG Capsule 1 cap(s) orally once a day
Progress Note: [PROVIDER_NAME], MD 01/23/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/16/2026 03:33 AM EDT
1/4
4/16/26, 12:34 AM Print Preview
[PATIENT_NAME] DOB: [DOB] ([AGE] yo M) Acc No. [ACCOUNT_ID] DOS: 01/23/2026
Tadalafil 5 MG Tablet 1 tab(s) orally once a day
Finasteride 5 MG Tablet 1 tab(s) orally once a day
Cialis(Tadalafil) 20 MG Tablet 1 tablet as needed Orally as needed
Not-Taking
metFORMIN HCl ER 500 MG Tablet Extended Release 24 Hour Oral
Meloxicam 15 MG Tablet Oral
Medication List reviewed and reconciled with the patient
Past Medical History
Mixed hyperlipidemia.
Essential (primary) hypertension.
Type 2 diabetes mellitus with unspecified complications.
Elevated prostate specific antigen (PSA).
Surgical History
prostate biopsy
colonoscopy 4/13/2018
Family History
Father: unknown
Mother: unknown
Social History
Recreational drug